Bosch Pharmaceuticals Pvt Ltd 4.78

Fastest Growing National Pharmaceuticals Company . . .

Today , Bosch is one of the fastest growing national pharmaceuticals company proud of the current market share of its products. Bosch Products have unique advantages in health care system. The Company is Continously Evaluating new prospects to add to the existing portfolio. The healing touch, It honors every individual rights to live without suffering & sickness. At BOSCH we dedicated ourselves to medical advancement in recognition of the fact that there can be no greater world than free from disease.

Bosch Pharmaceuticals is dedicated to enhancing human life through developments,manufacture and sale of quality pharmaceuticals products.The Company was established in 1994,with its main Office and manufacturing facility at karachi,Pakistan.Now progressing into 19th Year of service , Bosch Thanks to Doctors , Pharmacists and Health Care Institutions who posed trust in the Quality and efficacy of the Bosch Products.

Bosch Pharmaceuticals is built on a solid foundation of talented people, unparalleled research and development platform, a strong clinical and commercial presence and trust of its loyal quality conscious prescribers. These factors have enabled Bosch, in just 19 years, to grow from a bold young startup to a leading pharmaceutical company in Pakistan. The group was originally established in early 1970's as Munico Associates International (MAI Group of Companies), participating in counter trade and transactions for pharmaceutical goods with multinational companies all over the world. In 1988 Munico ventured into pharmaceutical packaging through Pakistan International Packages, involved in manufacturing of high quality glass ampoules and aluminium closures under German collaboration.



Bosch Pharmaceuticals established in 1994 owns a world class, latest and state of the art manufacturing facility situated in Korangi Industrial Area- Karachi, which stands amongst the top Six (6) pharmaceutical manufacturing facilities in Pakistan. Bosch also has the honor to be the first pharma plant in Pakistan to have seven separate sterile manufacturing facilities, along with two separate manufacturing plant for oral and parenteral penicillin formulations and separate manufacturing areas for cephalosporins, quinolones, ophthalmics and aminoglycosides Penicillin. Bosch is also has the honor to be the first Lyophilized manufacturing unit in Pakistan. Bosch having its partners in quality with world renowned names as Sandoz - Austria, Asahi Kasei-Japan, ACS Dobfar- Italy, Klockner Pentaplast- Germany, VAW-Germany, Saint Gobain- France, Color Con UK , Helvoet Pharma Belgium and Capsulit Italy is proud to be the pioneer and the largest producer of Cephlosporin specialities and amongst the largest producers of penicillins, aminoglycosides and quinolone specialities in Pakistan.


Besides contributing significantly to the economy through its growth, Bosch has also been a major employment provider all over Pakistan. With an initial employee base of 95 people in1994, Bosch currently employs more then 3000. Bosch is also contributing towards the economy of Pakistan through exports to South East Asia, Central Asia, Middle East and Africa with Europe, North and South America in the process. Bosch's growth motive is to 'believe in tomorrow and to fulfill it, extensive expansion plans are underway. To maintain the current GMP and meet the F.D. A. approval requirements through expansion of the current plant which had increased from 50,000 sq ft. in 1994 to 150,000 sq. ft in 2004. To meet the growth requirements upto 2020 , new plants are in plan, one for the basic raw material to be setup at Port Qasim and other to manufacture finished pharmaceutical products at Korangi Industrial Area. Bosch's vision is to provide quality medicines at an economical price for all classes of people and the same vision is shared by its team of highly qualified and dedicated professionals with vast experience in research, production and marketing of quality health care products.

We would like to thank valued prescribers who have made it a glorified decade for us. We feel proud on the current market share of our products. Each is research based and offers unique features to the health care system. We are continually evaluating new prospects for adding to our product portfolio.